man
return
nation
institut
health
nih
march
follow
allogen
hsct
initi
diagnos
preb
cell
acut
lymphoblast
leukemia
el
salvador
novemb
receiv
induct
chemotherapi
cyclophosphamid
vincristin
doxorubicin
dexamethason
cycl
intrathec
methotrex
follow
cycl
mainten
chemotherapi
bendamustin
methotrex
decemb
may
bone
marrow
biopsi
may
show
recurr
diseas
prompt
treatment
cycl
highdos
cytarabin
mitoxantron
repeat
bone
marrow
biopsi
show
morpholog
complet
remiss
receiv
continu
mainten
therapi
methotrex
monthli
intrathec
methotrex
present
nih
februari
human
leukocyt
antigenident
sibl
hsct
patient
gave
inform
consent
institut
review
boardapprov
protocol
nation
heart
lung
blood
institut
receiv
myeloabl
condit
fludarabin
cyclophosphamid
cgi
total
bodi
irradi
lung
shield
cgi
deplet
graft
graftversushost
diseas
gvhd
prophylaxi
cyclosporin
follow
full
engraft
immedi
posttranspl
cours
complic
escherichia
coli
urinari
tract
infect
clostridium
difficil
coliti
respiratori
syncyti
viru
infect
develop
grade
acut
gvhd
skin
brief
episod
cytomegaloviru
cmv
viremia
without
endorgan
diseas
parainfluenza
upper
respiratori
tract
infect
receiv
continu
prophylaxi
trimethoprimsulfamethoxazol
tmpsmx
acyclovir
antifung
prophylaxi
voriconazol
discontinu
week
posttranspl
secondari
elev
liver
enzym
followup
visit
nih
octob
asymptomat
donor
chimer
myeloid
cell
januari
el
salvador
develop
nonbloodi
diarrhea
treat
empir
local
physician
cours
prednison
resolut
diarrhea
seen
nih
march
routin
follow
asymptomat
deni
fever
chill
cough
dyspnea
nausea
vomit
abdomin
pain
diarrhea
urinari
symptom
rash
asid
aforement
resolv
diarrheal
episod
event
previou
month
medic
prophylact
tmpsmx
acyclovir
vital
sign
physic
examin
unremark
addit
medic
histori
asthma
hypothyroid
live
small
inland
town
el
salvador
travel
outsid
hometown
bethesda
maryland
year
posttransplant
pet
deni
tobacco
alcohol
illicit
drug
use
laboratori
result
follow
creatinin
mgdl
alanin
aminotransferas
ul
aspart
aminotransferas
ul
alkalin
phosphatas
ul
total
bilirubin
mgdl
white
blood
cell
count
neutrophil
lymphocyt
monocyt
eosinophil
hemoglobin
gdl
platelet
count
total
lymphocyt
total
cell
chimer
show
donor
lineag
routin
chest
xray
reveal
solitari
right
upper
lobe
nodul
measur
cm
seen
prior
xray
perform
octob
comput
tomographi
ct
scan
chest
reveal
right
upper
lobe
lung
lesion
measur
cm
longest
dimens
associ
groundglass
opac
lung
nodul
lesion
pleural
effus
seen
pet
scan
reveal
right
upper
lung
nodul
hypermetabol
activ
maximum
max
standard
uptak
valu
suv
also
focal
hypermetabol
right
hilum
associ
nonenlarg
mildli
hypermetabol
mediastin
node
includ
subcarina
activ
measur
max
suv
figur
c
patient
underw
bronchoscopi
bronchoalveolar
lavag
bal
brush
studi
reveal
endobronchi
lesion
plaqu
ulcer
abnorm
secret
gram
stain
reveal
moder
mononuclear
cell
neutrophil
organ
routin
bacteri
cultur
grew
oropharyng
flora
fungal
wet
mount
modifi
acidfast
bacilli
acidfast
bacilli
stain
neg
respiratori
viral
panel
detect
coronaviru
pneumocysti
jirovecci
direct
fluoresc
antibodi
pcr
neg
legionella
pneumophilia
pcr
legionella
cultur
neg
well
fungal
mycobacteri
nocardia
cultur
polymeras
chain
reaction
epsteinbarr
viru
ebv
cmv
herp
simplex
viru
neg
bal
pcr
ebv
cmv
adenoviru
blood
bal
galactomannan
antigen
neg
patient
underw
ctguid
biopsi
lung
nodul
hematoxylin
eosin
stain
show
area
necrosi
chronic
inflamm
mononuclear
cell
neutrophil
granuloma
seen
figur
grocottgomori
methenamin
silver
stain
reveal
small
narrowbud
yeast
cell
figur
stain
neg
mucicarmin
figur
bacteri
fungal
cultur
nodul
neg
deoxyribonucl
acid
dna
extract
formalinfix
paraffinembed
tissu
block
lung
biopsi
describ
previous
extract
dna
amplifi
use
panfung
primer
target
intern
transcrib
spacer
region
pcr
product
sequenc
sequenc
result
search
nation
center
biotechnolog
inform
databas
exhibit
ident
histoplasma
capsulatum
genbank
access
urin
serum
histoplasma
antigen
neg
patient
treat
oral
voriconazol
dose
mg
everi
hour
week
trough
level
toler
treatment
without
complic
ct
scan
el
salvador
approxim
month
complet
treatment
cours
reveal
decreas
size
lung
nodul
cm
return
nih
april
approxim
year
diagnosi
pulmonari
histoplasmosi
asymptomat
physic
examin
unremark
count
total
lymphocyt
total
cell
chimer
donor
lineag
repeat
ct
chest
scan
reveal
decreas
size
right
upper
lobe
nodul
cm
longest
dimens
figur
pet
scan
show
lesion
hypermetabol
figur
histoplasma
capsulatum
var
capsulatum
dimorph
fungu
found
worldwid
area
highest
endem
north
america
central
america
endem
area
major
infect
asymptomat
wide
spectrum
clinic
ill
rang
acut
chronic
pulmonari
infect
dissemin
histoplasmosi
incid
histoplasmosi
hsct
unknown
believ
rare
vail
et
al
retrospect
review
patient
receiv
allogen
hsct
endem
area
found
case
histoplasmosi
mean
follow
month
assi
et
al
retrospect
review
case
system
histoplasmosi
mayo
clinic
identifi
case
autolog
hsct
recipi
recent
kauffman
et
al
prospect
enrol
solid
organ
transplant
sot
hsct
recipi
diagnos
endem
mycos
march
septemb
hsct
recipi
case
histoplasmosi
identifi
contrast
case
histoplasmosi
identifi
sot
recipi
time
period
found
case
histoplasmosi
complic
allogen
hsct
english
literatur
pertin
case
detail
summar
tabl
along
patient
dissemin
isol
pulmonari
infect
report
week
month
posttransplant
patient
report
outcom
die
notabl
common
featur
case
includ
recent
receipt
corticosteroid
gvhd
treatment
patient
diagnos
earli
routin
imag
asymptomat
without
fever
respiratori
symptom
pet
scan
demonstr
pulmonari
nodul
associ
hilar
lymph
node
hypermetabol
indic
local
histoplasmoma
reactiv
region
lymph
node
although
usual
standard
care
use
pet
imag
previous
report
assist
diagnosi
histoplasmosi
invas
fungal
infect
gener
cultur
histoplasma
antigen
test
neg
patient
case
use
panfung
primer
amplifi
dna
organ
sequenc
vital
make
diagnosi
per
infecti
diseas
societi
america
manag
guidelin
histoplasmosi
treatment
recommend
asymptomat
pulmonari
nodul
howev
chose
treat
case
evid
activ
inflamm
histolog
pet
scan
patient
alter
immun
system
hsct
dismal
prognosi
histoplasmosi
patient
popul
tabl
monitor
itraconazol
level
patient
home
countri
difficult
choic
voriconazol
treatment
made
establish
level
discharg
review
literatur
suggest
histoplasmosi
rare
postallogen
hsct
howev
diagnosi
histoplasmosi
challeng
empir
preemptiv
antifung
treatment
often
administ
posthsct
like
incid
histoplasmosi
underestim
hsct
popul
therefor
use
pet
imag
molecular
diagnost
shown
case
may
lead
recognit
addit
case
histoplasmosi
reassess
incid
allogen
hsct
recipi
